FilingSEC EDGAR6-K
Adagene Achieves $2 Million Milestone in Collaboration with Exelixis
· SEC accepted
StagePreclinical
Filing content
Adagene achieved a preclinical milestone for its XB404 program under its collaboration with Exelixis, resulting in a $2 million payment.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…